SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001622627-24-000008
Filing Date
2024-02-14
Accepted
2024-02-14 20:43:22
Documents
2
Group Members
GIL AHARONROSALIND ADVISORS, INC.ROSALIND MASTER FUND L.P.STEVEN SALAMON

Document Format Files

Seq Description Document Type Size
1 rosalind_mdwd_13ga_1_dec.htm SC 13G/A 91193
2 exh_a_joint_filing.htm EX-99.A BD-DIR-RESOL 2268
  Complete submission text file 0001622627-24-000008.txt   95132
Mailing Address 42 HAYARKON STREET YAVNE L3 8122745
Business Address 42 HAYARKON STREET YAVNE L3 8122745 97289324010
MediWound Ltd. (Subject) CIK: 0001593984 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88069 | Film No.: 24641680
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)

Mailing Address 15 WELLESLEY STREET WEST SUITE 326 TORONTO A6 M4Y 0G7
Business Address 25 ADMIRAL ROAD TORONTO A6 M5R 2L4 4168887606
Rosalind Advisors, Inc. (Filed by) CIK: 0001622627 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: SC 13G/A